160 related articles for article (PubMed ID: 28336956)
21. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
[TBL] [Abstract][Full Text] [Related]
22. AMG 102, a fully human anti-hepatocyte growth factor/scatter factor neutralizing antibody, enhances the efficacy of temozolomide or docetaxel in U-87 MG cells and xenografts.
Jun HT; Sun J; Rex K; Radinsky R; Kendall R; Coxon A; Burgess TL
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6735-42. PubMed ID: 18006775
[TBL] [Abstract][Full Text] [Related]
23. Efficient Selection of Antibodies Reactive to Homologous Epitopes on Human and Mouse Hepatocyte Growth Factors by Next-Generation Sequencing-Based Analysis of the B Cell Repertoire.
Kim S; Lee H; Noh J; Lee Y; Han H; Yoo DK; Kim H; Kwon S; Chung J
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669409
[No Abstract] [Full Text] [Related]
24. Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain.
Park H; Kim D; Kim E; Sa JK; Lee HW; Yu S; Oh J; Kim SH; Yoon Y; Nam DH
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902178
[TBL] [Abstract][Full Text] [Related]
25. Probing conformational and functional states of human hepatocyte growth factor by a panel of monoclonal antibodies.
Umitsu M; Sakai K; Ogasawara S; Kaneko MK; Asaki R; Tamura-Kawakami K; Kato Y; Matsumoto K; Takagi J
Sci Rep; 2016 Sep; 6():33149. PubMed ID: 27608665
[TBL] [Abstract][Full Text] [Related]
26. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
27. A neutralizable epitope is induced on HGF upon its interaction with its receptor cMet.
Kim K; Hur Y; Ryu EK; Rhim JH; Choi CY; Baek CM; Lee JH; Chung J
Biochem Biophys Res Commun; 2007 Mar; 354(1):115-21. PubMed ID: 17214965
[TBL] [Abstract][Full Text] [Related]
28. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
[TBL] [Abstract][Full Text] [Related]
29. Initial testing (Stage 1) of TAK-701, a humanized hepatocyte growth factor binding antibody, by the Pediatric Preclinical Testing Program.
Houghton PJ; Kurmasheva RT; Kolb EA; Wu J; Gorlick R; Maris JM; Smith MA
Pediatr Blood Cancer; 2014 Feb; 61(2):380-2. PubMed ID: 24019233
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.
Phan LM; Fuentes-Mattei E; Wu W; Velazquez-Torres G; Sircar K; Wood CG; Hai T; Jimenez C; Cote GJ; Ozsari L; Hofmann MC; Zheng S; Verhaak R; Pagliaro L; Cortez MA; Lee MH; Yeung SC; Habra MA
Cancer Res; 2015 Oct; 75(19):4131-42. PubMed ID: 26282167
[TBL] [Abstract][Full Text] [Related]
32. Local administration of anti-hepatocyte growth factor-neutralizing antibody reverts naturally occurring periodontitis.
Yamaguchi Y; Ohshima M
J Oral Biosci; 2021 Sep; 63(3):245-252. PubMed ID: 34303825
[TBL] [Abstract][Full Text] [Related]
33. Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling.
Hultberg A; Morello V; Huyghe L; De Jonge N; Blanchetot C; Hanssens V; De Boeck G; Silence K; Festjens E; Heukers R; Roux B; Lamballe F; Ginestier C; Charafe-Jauffret E; Maina F; Brouckaert P; Saunders M; Thibault A; Dreier T; de Haard H; Michieli P
Cancer Res; 2015 Aug; 75(16):3373-83. PubMed ID: 26141862
[TBL] [Abstract][Full Text] [Related]
34. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
Abounader R; Lal B; Luddy C; Koe G; Davidson B; Rosen EM; Laterra J
FASEB J; 2002 Jan; 16(1):108-10. PubMed ID: 11729097
[TBL] [Abstract][Full Text] [Related]
35. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
[TBL] [Abstract][Full Text] [Related]
36. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met.
Koh YW; Choi EC; Kang SU; Hwang HS; Lee MH; Pyun J; Park R; Lee Y; Kim CH
J Nutr Biochem; 2011 Nov; 22(11):1074-83. PubMed ID: 21292466
[TBL] [Abstract][Full Text] [Related]
37. The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy.
Chen L; Li C; Zhu Y
Oncotarget; 2015 Oct; 6(30):30088-101. PubMed ID: 26254225
[TBL] [Abstract][Full Text] [Related]
38. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.
Uchinokura S; Miyata S; Fukushima T; Itoh H; Nakano S; Wakisaka S; Kataoka H
Int J Cancer; 2006 Feb; 118(3):583-92. PubMed ID: 16106403
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
Heideman DA; Overmeer RM; van Beusechem VW; Lamers WH; Hakvoort TB; Snijders PJ; Craanen ME; Offerhaus GJ; Meijer CJ; Gerritsen WR
Cancer Gene Ther; 2005 Dec; 12(12):954-62. PubMed ID: 15905856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]